Department of Health Care Policy, Harvard Medical School, 180A Longwood Avenue, Boston, MA, 02115, USA.
University of California San Diego, San Diego, CA, USA.
J Gen Intern Med. 2023 Jul;38(9):2139-2146. doi: 10.1007/s11606-023-08165-9. Epub 2023 Mar 24.
During the pandemic, there was a dramatic shift to telemedicine for opioid use disorder (OUD) treatment. Little is known about how clinician attitudes about telemedicine use for OUD treatment are evolving or their preferences for future use.
To understand OUD clinician views of and preferences regarding telemedicine.
Longitudinal survey (wave 1, December 2020; wave 2, March 2022).
National sample of 425 clinicians who treat OUD.
Self-reported proportion of OUD visits delivered via telemedicine (actual vs. preferred), comfort in using video visits for OUD, impact of telemedicine on work-related well-being.
The mean reported percentage of OUD visits delivered via telemedicine (vs. in person) dropped from 56.9% in December 2020 to 41.5% in March 2022; the mean preferred post-pandemic percentage of OUD visits delivered via telemedicine was 34.8%. Responses about comfort in using video visits for different types of OUD patients remained similar over time despite clinicians having substantially more experience with telemedicine by spring 2022 (e.g., 35.8% vs. 36.0% report being comfortable using video visits for new patients). Almost three-quarters (70.9%) reported that most of their patients preferred to have the majority of their visits via telemedicine, and 76.7% agreed that the option to do video visits helped their patients remain in treatment longer. The majority (58.7%) reported that telemedicine had a positive impact on their work-related well-being, with higher rates of a positive impact among those who completed training more recently (68.5% of those with < 10 years, 62.1% with 10-19 years, and 45.8% with 20 + years, p < 0.001).
While many surveyed OUD clinicians were not comfortable using telemedicine for all types of patients, most wanted telemedicine to account for a substantial fraction of OUD visits, and most believed telemedicine has had positive impacts for themselves and their patients.
在大流行期间,远程医疗治疗阿片类药物使用障碍(OUD)的方式发生了重大转变。对于临床医生对 OUD 治疗中使用远程医疗的态度如何演变,以及他们对未来使用的偏好,知之甚少。
了解 OUD 临床医生对远程医疗的看法和偏好。
纵向调查(第 1 波,2020 年 12 月;第 2 波,2022 年 3 月)。
全国 425 名治疗 OUD 的临床医生。
通过远程医疗(实际与偏好)提供的 OUD 就诊比例的自我报告,使用视频就诊治疗 OUD 的舒适度,远程医疗对工作相关幸福感的影响。
通过远程医疗(而非面对面)提供的 OUD 就诊比例的平均报告百分比从 2020 年 12 月的 56.9%下降到 2022 年 3 月的 41.5%;平均偏好的大流行后通过远程医疗提供的 OUD 就诊比例为 34.8%。尽管到 2022 年春季,临床医生通过远程医疗获得了更多的经验,但有关不同类型 OUD 患者使用视频就诊的舒适度的回答在时间上保持相似(例如,分别有 35.8%和 36.0%的受访者表示对新患者使用视频就诊感到舒适)。近四分之三(70.9%)的人报告说,他们的大多数患者更希望通过远程医疗进行大多数就诊,并且 76.7%的人同意视频就诊的选择有助于他们的患者更长时间地接受治疗。大多数(58.7%)人报告说远程医疗对他们的工作相关幸福感产生了积极影响,而最近完成培训的人的积极影响更高(10 年以下的比例为 68.5%,10-19 年的比例为 62.1%,20 年以上的比例为 45.8%,p<0.001)。
虽然许多接受调查的 OUD 临床医生对使用远程医疗治疗所有类型的患者并不感到舒适,但大多数人希望远程医疗在 OUD 就诊中占很大比例,并且大多数人认为远程医疗对他们自己和患者都有积极的影响。